On this special bonus episode of The Ethics Experts, we speak with Charlotte Marshall about public brand, employer brand, and how companies should publish the vulnerabilities of employee roles, rather than just the strengths.
Check out more episodes, and don’t forget to subscribe on your favorite podcast platform!
On this episode of The Ethics Experts, we speak with Frank Galea about the history of compliance in financial services, and how compliance officers had to get their act together or be personally liable.
Check out more episodes, and don’t forget to subscribe on your favorite podcast platform!
Determining effectiveness is a key part of continuous improvement. Yet how to do so still bedevils many compliance professionals. You need to consider both outcomes and outputs. Outcomes will show you the results of specific actions, such as investigations and conclusions to them. Numbers are attractive because they can form a “straight line” about how your compliance program is functioning. But you must remember that the numbers only give you one view of a compliance program. You also need to consider the qualitative side of the equation.
There is the need for both a quantitative and qualitative approach to measuring compliance program effectiveness. Numbers are important but they only tell part of the equation. Vin DiCianni has said, “Both are very important, but I think without having consideration of both sides of the equation, you will not obtain a full understanding of how effective compliance program is in its operation.”
Three key takeaways:
Amanda zooms with show regular Chris Martin about how to stay compliant while working from home.
Check out more episodes and full episode videos at ComplianceLine.com, and don’t forget to subscribe on your favorite podcast platform!
Welcome to the newest addition to the Compliance Podcast Network, Compliance and Coronavirus. As the Voice of Compliance, I wanted to start a podcast which will help to bring both clarity and sanity to the compliance practitioner and compliance profession during this worldwide health and healthcare crisis. In this episode, I am joined by Sundar Narayanan, Director at Nexdigm. We explore a recent blog post by Narayanan on the FCPA Blog, Compliance officers can be pillars of empathy during the outbreak.
Resources
For additional reading see Compliance officers can be pillars of empathy during the outbreak
For more information on Nexdigm, see their website
For more information on Sundar Narayana, see his Linkedin profile
This podcast is sponsored by SAI Global. To learn how you can protect your business operations and workforce during these uncertain times, visit saiglobal.com/risk for free resources, expert guidance, and industry-leading technology.
In this episode we discuss how an independent integrity review can be helpful for organizations that may be facing actual or potential compliance issues. We consider some of the following are whether an independent integrity review and monitoring be helpful where a healthcare organization may have reason to believe it has an actual or potential compliance problem, but has not yet been subject to an enforcement action or a corporate integrity agreement imposed by the government? How can engaging an independent integrity monitor help an organization in dealing with an enforcement agency? Why do government enforcement and regulatory agencies prefer not to exclude important health care providers who have compliance issues?
In this episode, we consider examples of independent monitoring involving healthcare organizations or systems. Issues considered are how do healthcare organizations or the agencies that regulate them may use monitoring in connection with significant business transactions – as opposed to law enforcement or disciplinary proceedings? Examples where organizations and government regulators have jointly agreed to use an independent firm to monitor implementation and compliance with conditions of a healthcare transactions.
In this episode, Jesse Caplan discusses how health regulatory agencies are using independent monitoring to serve important public policy goals – specifically to help ensure a ready supply of quality healthcare providers, particularly for government programs like Medicaid and Medicare.
In this Jesse Caplan and Tom Fox discuss how healthcare organizations can identify and mitigate the risks from opioid prescribing by their practitioners. Some of the issues considered are what can healthcare organizations, and particularly their compliance departments do to identify and mitigate the risks from opioid prescribing? Some examples of deficient opioid prescribing practices by, otherwise, experienced and caring physicians? What help is available to healthcare organizations to address these risks?
